Profil
Jennifer Fitzpatrick is currently the Vice President & Corporate Counsel at SAGE Therapeutics, Inc. She previously worked as Secretary & Director at Aegerion Pharmaceuticals, Inc.
Postes actifs de Jennifer Fitzpatrick
| Sociétés | Poste | Début |
|---|---|---|
| SAGE THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Anciens postes connus de Jennifer Fitzpatrick
| Sociétés | Poste | Fin |
|---|---|---|
| AEGERION PHARMACEUTICALS, INC. | Director/Board Member | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SAGE THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Aegerion Pharmaceuticals, Inc.
 Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aegerion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development and commercialization of therapies for patients with debilitating rare diseases. The company was founded by David I. Scheer, Gerald L. Wisler and William H. Lewis in 2005 and is headquartered in Cambridge, MA. | Health Technology |
